Choksi Laboratories Ltd.

66.51 +1.30 ▲2.0%

26 April 2024, 04:01:00 PM
Volume: 21,487

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.choksilab.com
Market Cap 46.33 Cr.
Enterprise Value(EV) 85.44 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 4.90 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 13.58 Trailing Twelve Months Ending 2023-12
Industry PE 66.96 Trailing Twelve Months Ending 2023-12
Book Value / Share 31.07 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.14 Calculated using Price: 66.51
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.70 Cr. 6,965,263 Shares
FaceValue 10
About Choksi Laboratories Ltd.
Established in 1982, Choksi Laboratories Limited (CLL), is more widely known as a leading analysis and research group, providing complete solutions for improving quality in processes, products and services.

Choksi Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Choksi Laboratories Ltd. Performance

1 Day
+1.99%
1 Week
+23.90%
1 Month
+44.24%
3 Month
+3.92%
6 Month
+0.77%
1 Year
+48.49%
2 Year
+133.37%
5 Year
+375.07%
10 Year
+798.78%

Choksi Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 4.45 3.67 4.34 6.19 6.9 -17.57 -13.74 1.16 16.46
Return on Capital Employed (%) 9.39 7.32 8.41 10.49 10.14 -8.27 0.02 6.75 13.9
Return on Assets (%) 2.31 1.8 2.15 3.16 3.2 -6.53 -4.06 0.32 5.24

Choksi Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 19 20 21 22 24 20 18 18 21 22
Non Curr. Liab. 6 9 5 7 18 29 31 30 26 21
Curr. Liab. 12 14 14 16 13 14 16 16 13 28
Minority Int.
Equity & Liab. 38 43 41 45 55 64 65 63 59 70
Non Curr. Assets 23 28 28 30 39 47 52 49 46 46
Curr. Assets 15 15 13 15 16 17 13 14 14 24
Misc. Exp. not W/O
Total Assets 38 43 41 45 55 64 65 63 59 70

Choksi Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 22 22 29 31 34 28 26 30 34 35
Other Income 1 0 1 0 0 0 0 0 0 0
Total Income 23 22 30 32 34 28 26 30 35 35
Total Expenditure -17 -17 -24 -25 -26 -25 -22 -21 -24 -25
PBIDT 6 5 6 7 8 3 5 9 10 10
Interest -2 -1 -1 -2 -2 -2 -3 -3 -4 -3
Depreciation -3 -3 -3 -3 -4 -5 -5 -5 -6 -6
Taxation -1 0 0 -1 -1 2 0 0 -1 0
Exceptional Items -2 2 2
PAT 1 1 1 1 2 -4 -3 0 3 3
Adjusted EPS 1 1 1 2 2 -6 -4 0 5 5

Choksi Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 2 7 7 6 7 3 6 8 8
Cash Fr. Inv. -6 -1 -7 -2 -5 -10 -14 -8 -3 -1
Cash Fr. Finan. 1 -1 1 -5 -1 2 11 2 -5 -8
Net Change -1 0 0 0 0 -1 0 0 0 0
Cash & Cash Eqvt 1 1 1 1 1 0 0 0 0 0

Choksi Laboratories Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 31.48 31.48 31.48 31.48 31.48 31.48 31.48 31.48 31.48
Public 68.52 68.52 68.52 68.52 68.52 68.52 68.52 68.52 68.52
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Choksi Laboratories Ltd. Announcements

Mon, 22 Apr 2024
Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended 31St March 2024.
Pursuant to Regulation 40(9) of SEBI (LODR) Regulations 2015 annexed herewith the certificate of compliance issued by PCS for the Financial Year ended 31st March 2024.
Thu, 18 Apr 2024
Compliance Certificate - Regulation 7 (3) Of SEBI (LODR) Regulations 2015.
Compliance Certificate in pursuant to Regulation 7(3) of SEBI (LODR) 2015 for the year ended 31.03.2024.
Thu, 11 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 annexed herewith the certificate received from RTA for the quarter ended 31.03.2024

Choksi Laboratories Ltd. Technical Scans

Fri, 26 Apr 2024
Opening at High Opening at High
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Closing Above Previous High For 3 Days Closing Above Previous High For 3 Days
Making Higher Highs for 3 days Making Higher Highs for 3 days

Choksi Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,919.96 1,506.55 -0.9%
Cipla Ltd. 113,539.92 1,409.15 +0.2%
Divi's Laboratories Ltd. 106,860.39 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. 104,489.96 6,252.10 +0.5%
Zydus Lifesciences Ltd. 95,411.11 947.40 -0.4%
Mankind Pharma Ltd. 94,538.87 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. 91,084.13 2,691.00 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.52 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 30.62 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 77.27 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.99 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 54.74 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.97 2,691.00 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.78 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 4.38 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 8.20 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.89 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.06 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.64 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.74 2,691.00 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,691.00 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,691.00 -0.1%

Choksi Laboratories Ltd. FAQ's

What is Choksi Lab share price?

Can I buy Choksi Lab shares now?

What is the Market Cap of Choksi Lab?

What are the key metrics to analyse Choksi Lab?

What is the 52 Week High and Low of Choksi Lab?

What is the trend of Choksi Lab share price?